Quotables
"The man with a new idea is a crank until the idea succeeds."
Samuel Clemens
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7507726 | Peptide deformylase inhibitors Novel PDF inhibitors and novel methods for their use are provided. ... | 03/24/2009 |
| 7456211 | Peptide deformylase inhibitors The present invention involves novel anti-bacterial compounds represented by Formula (I), pharmaceutical compositions thereof, their use as PDF inhibitors, and their use in the treatment of bacterial infections. ... | 11/25/2008 |
| 7446108 | Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention hav... | 11/04/2008 |
| 7442793 | Peptide deformylase inhibitors Novel PDF inhibitors and novel methods for their use are provided. ... | 10/28/2008 |
| 7375131 | NF-κB inhibitors The present invention provides novel compounds and methods for using them to treat diseases with aminothiophene inhibitors of IKK-β phosphorylation of IκB. In so doing these aminothiophene inhibitors block pathological activation of transcription factor NF-κB in ... | 05/20/2008 |
| 7375120 | Peptide deformylase inhibitors Novel PDF inhibitors and novel methods for their use are provided. ... | 05/20/2008 |
| 7232902 | Process to prepare (1-carboxymethyl)-pyrimidinone compounds The invention relates to a process for the preparation of certain pyrimidinone compounds. ... | 06/19/2007 |
| 7232841 | Mmuscarinic acetylcholine receptor antagonists Novel thiazole aniline compounds, pharmaceutical compositions, methods of making them and uses thereof in treating M3 muscarinic acetylcholine receptor mediated diseases are disclosed. ... | 06/19/2007 |
| 7109213 | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them Aminopiperidine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man. ... | 09/19/2006 |
| 7109238 | Calcilytic compounds Novel calcilytic compounds and methods of using them are provided. ... | 09/19/2006 |
| 7038055 | Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies A compound of formula (I) useful in the treatment and prophylaxis of conditions mediated by s-CD23 ... | 05/02/2006 |
| 6987119 | Imidazol-2-carboxamide derivatives as raf kinase inhibitors Compounds of formula (I): wherein X is O, CH2, S or NH, or the moiety X—R1 is hydrogen; V is CH or N; R1 is hydrogen, C1-6 | 01/17/2006 |
| 6939891 | Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists The invention relates to certain novel compounds having Vanilloid Receptor (VR1) antagonist activity, processes for their preparation, to compositions containing them and to their use in the treatment of various disorders. ... | 09/06/2005 |
| 6911442 | Quinoline derivatives as antibacterials The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or N-oxide thereof: corresponding novel medicaments, pharmaceutical compositions and/or methods of ... | 06/28/2005 |
| 6897233 | Peptide deformylase inhibitors PDF inhibitors and novel methods for their use are provided. ... | 05/24/2005 |
| 6806369 | Peptide deformylase inhibitors PDF inhibitors and novel methods for their use are provided. ... | 10/19/2004 |
| 6797730 | Peptide deformylase inhibitors Novel PDF inhibitors and novel methods for their use are provided. ... | 09/28/2004 |
| 6613785 | Use of glucose uptake enhancer for reducing post-ischemic injury of the heart A method for reducing post-ischaemic injury of the heart and/or improving the functional recovery of the heart following myocardial ischaemia which method comprises administration of an effective, non-toxic amount of a glucose uptake enhancer to a human o... | 09/02/2003 |
